Clinical Trial Update: Immunogenetics of Visceral Leishmaniasis

View source ↗

Summary

An NHGRI-sponsored study investigating the immunogenetics of visceral leishmaniasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Snippet

Sponsor: National Human Genome Research Institute (NHGRI) | Conditions: Visceral Leishmaniasis | Status: COMPLETED